Renaissance Technologies’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,496
| Closed | -$19.5K | – | 3691 |
|
|
2024
Q4 | $19.5K | Buy |
11,496
+500
| +5% | +$850 | ﹤0.01% | 3483 |
|
|
2024
Q3 | $31.2K | Buy |
+10,996
| New | +$31.2K | ﹤0.01% | 3395 |
|
|
2024
Q1 | – | Sell |
-8,640
| Closed | -$111K | – | 3924 |
|
|
2023
Q4 | $111K | Buy |
8,640
+627
| +8% | +$8.06K | ﹤0.01% | 3279 |
|
|
2023
Q3 | $51K | Sell |
8,013
-480
| -6% | -$3.06K | ﹤0.01% | 3398 |
|
|
2023
Q2 | $74K | Buy |
8,493
+2,186
| +35% | +$19K | ﹤0.01% | 3533 |
|
|
2023
Q1 | $91K | Buy |
6,307
+827
| +15% | +$11.9K | ﹤0.01% | 3517 |
|
|
2022
Q4 | $87K | Sell |
5,480
-153
| -3% | -$2.43K | ﹤0.01% | 3661 |
|
|
2022
Q3 | $90K | Sell |
5,633
-240
| -4% | -$3.84K | ﹤0.01% | 3628 |
|
|
2022
Q2 | $128K | Buy |
5,873
+1,880
| +47% | +$41K | ﹤0.01% | 3782 |
|
|
2022
Q1 | $107K | Buy |
3,993
+1,766
| +79% | +$47.3K | ﹤0.01% | 3781 |
|
|
2021
Q4 | $62K | Buy |
+2,227
| New | +$62K | ﹤0.01% | 3758 |
|
|
2021
Q1 | – | Sell |
-10,539
| Closed | -$756K | – | 3550 |
|
|
2020
Q4 | $756K | Buy |
10,539
+637
| +6% | +$45.7K | ﹤0.01% | 2634 |
|
|
2020
Q3 | $724K | Sell |
9,902
-5,293
| -35% | -$387K | ﹤0.01% | 2671 |
|
|
2020
Q2 | $1.32M | Buy |
15,195
+1,151
| +8% | +$100K | ﹤0.01% | 2410 |
|
|
2020
Q1 | $770K | Buy |
14,044
+2,851
| +25% | +$156K | ﹤0.01% | 2549 |
|
|
2019
Q4 | $922K | Buy |
11,193
+801
| +8% | +$66K | ﹤0.01% | 2673 |
|
|
2019
Q3 | $1.04M | Buy |
10,392
+1,129
| +12% | +$113K | ﹤0.01% | 2579 |
|
|
2019
Q2 | $1.04M | Buy |
9,263
+7,517
| +431% | +$846K | ﹤0.01% | 2660 |
|
|
2019
Q1 | $127K | Buy |
1,746
+1,285
| +279% | +$93.5K | ﹤0.01% | 3275 |
|
|
2018
Q4 | $43K | Buy |
+461
| New | +$43K | ﹤0.01% | 3297 |
|